Showing 31-40 of 43 results for "".
- FDA Approves of Sol Gel's Twyneo for Acnehttps://practicaldermatology.com/news/fda-approves-of-sol-gels-twyneo-for-acne/2460874/The FDA has approved Sol Ge's first proprietary drug product, TWYNEO (tretinoin/benzoyl peroxide) cream, 0.1%/3%, for the treatment of acne vulgaris in adults and pediatric patients nine years of age and older. TWYNEO uses Sol-Gel’s patented technology to entrap tretinoin, a retinoid, and benzoyl p…
- New NRS Study Shows Positive Impact of Clear Skin in Rosacea Patientshttps://practicaldermatology.com/news/new-nrs-study-shows-positive-impact-of-clear-skin-in-rosacea-patients/2460048/Treating rosacea can have a major positive impact on patients’ lives, according to a new survey by the National Rosacea Society. In the survey of 1,044 rosacea patients, around 76 percent of all respondents saw at least some improvement in their skin after receiving treatment. Among those patients…
- BioPharmX: FDA Grants CARC Waiver; Post-Hoc Analysis for BPX-01 Completehttps://practicaldermatology.com/news/biopharmx-fda-grants-carc-waiver-post-hoc-analysis-for-bpx-01-complete/2457686/The FDA has waived its requirement for a dermal carcinogenicity study for BPX-01 from BioPharmX Corporation, eliminating several years of non-clinical research normally required for FDA review. BPX-01, a novel topical gel formulation of minocycline for the treatment of inflammatory acne, received …
- NRS Roundtable: Greater Focus on Facial Erythema in Rosacea Warrantedhttps://practicaldermatology.com/news/nrs-roundtable-greater-focus-on-facial-erythema-in-rosacea-warrated/2460392/Dermatologists should place greater emphasis on addressing persistent facial erythema in roscaea, according to experts at a recent National Rosacea Society (NRS) roundtable. Drawing from current scientific knowledge as well as clinical experience, the new standard classification of rosacea shifted…
- Randy Baldwinhttps://practicaldermatology.com/profiles/randy-baldwin/Ld9GEm/
- Laura Baldwin, CPC, ELI-NP, RNhttps://practicaldermatology.com/profiles/laura-baldwin-cpc-eli-np-rn/jG8EA1/
Conversations in Acne, Part 2
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-2/19871/From isotretinoin to antibiotics—including next generation tetracyclines—the experts talk about key considerations for optimal outcomes, including the impact of diet. They also discuss management of trunk acne and strategies to reduce the risk for bacterial resistance. Host Neal Bhatia, MD leads theConversations in Acne, Part 1
https://practicaldermatology.com/topics/acne-rosacea/conversations-in-acne-part-1/19867/As treatment options for acne expand, clinicians consider the potential to combine topical therapies or pair topicals with systemics, all while adhering to guidelines for care and prescribing antibiotics responsibly. In the first episode of this three-part series, host Neal Bhatia, MD speaks with Hi- Supergoop! Founder & CEO Named Ernst & Young LLP’s Entrepreneurs of the Year for 2022https://practicaldermatology.com/news/supergoop-founder-ceo-named-ernst-young-llps-entrepreneurs-of-the-year-for-2022/2461430/Holly Thaggard and Amanda Baldwin of Supergoop! are Ernst & Young LLP’s Entrepreneurs of the Year for 2022. The Entrepreneur of the Year program honors and elevates entrepreneurs who think big and act boldly to change our world for nearly four decades. Holly and Amanda were selected by an indepen…
- Galderma Launches Twyneo in the UShttps://practicaldermatology.com/news/galderma-launches-twyneo-in-the-us/2461128/Galderma has launched Twyneo (tretinoin and benzoyl peroxide) Cream, 0.1%/3% in the US. The launch takes place during the annual meeting of the American Academy of Dermatology (AAD) Annual Meeting. Twyneo Cream features patented microencapsulation technology that allows the delivery of two ingredie…